Citadel Advisors »

Inmed Pharmaceuticals shares owned by Citadel Advisors

Quarter-by-quarter ownership of Inmed Pharmaceuticals (INM) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Inmed Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Inmed Pharmaceuticals held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inmed Pharmaceuticals by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $14k 34k 0.42

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Microsoft Corporation Call Option (MSFT)
Meta Platforms Cl A Call Option (META)
Apple Call Option (AAPL)
Amazon Call Option (AMZN)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Advanced Micro Devices Call Option (AMD)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl C Call Option (GOOG)
Booking Holdings Call Option (BKNG)

View all positions for Citadel Advisors

Top funds holding Inmed Pharmaceuticals

Citadel Advisors
Two Sigma Securities
BFSG
Bank of America Corporation
TD Waterhouse Canada
AdvisorNet Financial
Advisory Services Network
Advisor Group Holdings
AllSquare Wealth Management
National Bank Of Canada /fi/
Royal Bank of Canada
Global Retirement Partners
Gables Capital Management

View all funds holding Inmed Pharmaceuticals